OTCMarketsExpert

FDA brings they Buyers back into Curaleaf Holdings.

Long
OTC:CURLF   Curaleaf Hldgs Inc.
Maybe not exactly what they Bears expected to happen but Curaleaf Management have actually turned a bad situation into a positive, rather than fighting the FDA, a warm welcome has been extended a proactive measures taken to comply.
The company is in a high growth trajectory and maybe see the FDA involvement as the start of washing the bad actors out of the retail side of the industry.
AVERAGE ANALYSTS PRICE TARGET $19.30
AVERAGE ANALYSTS RECOMMENDATION BUY
P/E RATIO
SHORT INTEREST

COMPANY PROFILE
Curaleaf Holdings, Inc. is a life science company, which engages in owning and managing licensed cannabis businesses which cultivate, process and/or dispense cannabis and cannabis derived products. It operates through Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how, and back office administration, intellectual property licensing,real estate leasing services, and lending facilities to medical and adult-use cannabis licensee. The company was founded on November 13, 2014 and is headquartered in Vancouver, Canada.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.